A prospective randomized controlled study to determine the role of chemical thrombo-prophylaxis in patients undergoing arthroscopic anterior cruciate ligament reconstructive surgery

Dinshaw Pardiwala0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1Patients undergoing arthroscopic ACL reconstruction (with or without associated meniscus or chondral surgery)
•2.Age group 16 to 60 year
•3Gender Male and female patients will be included
•4Patients who would voluntarily agree to sign informed consent form
•5.Patients who would be available to perform the postoperative color Doppler evalua-tion at KDAH.

•1Patients undergoing arthroscopic ACL reconstruction associated with other ligament re-constructive surgery that is arthroscopic bicruciate reconstructions and multiple ligament reconstructions
•2Age group : <16 years & >60 years
•3Patients diagnosed with acute or chronic DVT on preoperative venous color Doppler
•4Patients having a high risk of DVT which would under normal circumstances warrant mandatory chemical thromboprophylaxis including previous history of DVT or PE, his-tory of recent malignancy (within the past 12 months), pregnancy, or patients on oral contraceptives.
•5History of thrombophilic conditions
•6A patient having more than 3 risk factors for developing DVT would be excluded. These include : smoking, nicotine abuse, hormonal replacement therapy, antipsychotic treatment, varicose vein, family history of thrombosis, ongoing treatment with steroids, anticoagulant or antiplatelet agents, history of gastrointestinal bleeding in the past 2 weeks

发起方

Dinshaw Pardiwala